1-1 of 1
Laura Versmee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 study of ktx-1001, a first-in-class oral MMSET/NSD2 inhibitor, demonstrates clinical activity in relapsed/refractory multiple myeloma

Free
Saad Usmani, Pierre Bories, Cristina Gasparetto, David Dingli, Sagar Lonial, David Siegel, Andrew Yee, Cindy Varga, Suzanne Trudel, Laura Rosiñol Dachs, Paula Rodriguez-Otero, Salomon Manier, Jesús Berdeja, Aimaz Afrough, Warren Baker, Seyed Alireza Hasheminasab, Anjan Thakurta, Vinidhra Sridharan, Erin Flynt, Miriam Barnett, Laura Versmee, María-Victoria Mateos, Cyrille Touzeau, Alfred Chung, Vivek Roy, Edward Stadtmauer
Journal: Blood
Blood (2025) 146 (Supplement 1): 250.
https://doi.org/10.1182/blood-2025-250
Published: 2025